These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36132135)
1. Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation. Nocera L; Fallara G; Raggi D; Belladelli F; Robesti D; Montorsi F; Karakiewicz PI; Malavaud B; Ploussard G; Necchi A; Martini A Front Oncol; 2022; 12():955894. PubMed ID: 36132135 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. Bosma NA; Warkentin MT; Gan CL; Karim S; Heng DYC; Brenner DR; Lee-Ying RM Eur Urol Open Sci; 2022 Mar; 37():14-26. PubMed ID: 35128482 [TBL] [Abstract][Full Text] [Related]
3. First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium. Dudani S; Graham J; Wells JC; Bakouny Z; Pal SK; Dizman N; Donskov F; Porta C; de Velasco G; Hansen A; Iafolla M; Beuselinck B; Vaishampayan UN; Wood LA; Liow E; Yan F; Yuasa T; Bjarnason GA; Choueiri TK; Heng DYC Eur Urol; 2019 Dec; 76(6):861-867. PubMed ID: 31445844 [TBL] [Abstract][Full Text] [Related]